Serotonin receptors are involved in the spinal mediation of descending facilitation of surgical incision-induced increase of Fos-like immunoreactivity in rats

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Silveira, João W S ^a   Dias, Quintino M ^a   Del Bel, Elaine A ^a   Prado, Wiliam A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; KETANSERIN; METHYSERGIDE; METITEPINE; PHENOXYBENZAMINE; PROTEIN C FOS; SEROTONIN RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN; SEROTONIN ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG RESPONSE; IMMUNOREACTIVITY; MALE; MOUSE; NERVE CELL; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINAL CORD; ANIMAL; CYTOLOGY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; PAIN; PAIN ASSESSMENT; POSTOPERATIVE PAIN; RAT; WISTAR RAT;

ANIMALS; ATROPINE; CHOLINERGIC ANTAGONISTS; IMMUNOHISTOCHEMISTRY; KETANSERIN; MALE; METHIOTHEPIN; METHYSERGIDE; NEURONS; NOREPINEPHRINE; PAIN; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PHENOXYBENZAMINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SPINAL CORD;

EID: 77952297592     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-6-17     Document Type: Article

References (103)

1. Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev 2004, 27:729-737. 10.1016/j.neubiorev.2003.11.008, 15019423.
2. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991, 14:219-245. 10.1146/annurev.ne.14.030191.001251, 1674413.
3. Kovelowski CJ, Ossipov MH, Sun H, Lai J, Malan TP, Porreca F. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain 2000, 87:265-273. 10.1016/S0304-3959(00)00290-6, 10963906.
4. Pertovaara A, Wei H, Hamalainen MM. Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats. Neurosci Lett 1996, 218:127-130. 10.1016/S0304-3940(96)13136-0, 8945744.
5. Vaccarino AL, Melzack R. Temporal processes of formalin pain: differential role of the cingulum bundle, fornix pathway and medial bulboreticular formation. Pain 1992, 49:257-271. 10.1016/0304-3959(92)90150-A, 1608649.
6. Wiertelak EP, Roemer B, Maier SF, Watkins LR. Comparison of the effects of nucleus tractus solitarius and ventral medial medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res 1997, 748:143-150. 10.1016/S0006-8993(96)01289-9, 9067455.
7. Pertovaara A. A neuronal correlate of secondary hyperalgesia in the rat spinal dorsal horn is submodality selective and facilitated by supraspinal influence. Exp Neurol 1998, 149:193-202. 10.1006/exnr.1997.6688, 9454628.
8. Zhuo M, Gebhart GF. Biphasic modulation of spinal nociceptive transmission from the medullary raphe nuclei in the rat. J Neurophysiol 1997, 78:746-758.
9. Calejesan AA, Ch'ang MH, Zhuo M. Spinal serotonergic receptors mediate facilitation of a nociceptive reflex by subcutaneous formalin injection into the hindpaw in rats. Brain Res 1998, 798:46-54. 10.1016/S0006-8993(98)00394-1, 9666072.
10. Wei F, Dubner R, Ren K. Nucleus reticularis gigantocellularis and nucleus raphe magnus in the brain stem exert opposite effects on behavioral hyperalgesia and spinal Fos protein expression after peripheral inflammation. Pain 1999, 80:127-141. 10.1016/S0304-3959(98)00212-7, 10204725.
11. Millan MJ. Descending control of pain. Prog Neurobiol 2002, 66:355-474. 10.1016/S0301-0082(02)00009-6, 12034378.
12. Millan MJ, Girardon S, Bervoets K. 8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206,553. Neuropharmacology 1997, 36:743-745. 10.1016/S0028-3908(97)00071-3, 9225301.
13. Stanfa LC, Dickenson AH. Enhanced alpha-2 adrenergic controls and spinal morphine potency in inflammation. Neuroreport 1994, 5:469-472. 10.1097/00001756-199401120-00025, 8003677.
14. Eisenach JC. Muscarinic-mediated analgesia. Life Sci 1999, 64:549-554. 10.1016/S0024-3205(98)00600-6, 10069522.
15. Zahn PK, Brennan TJ. Incision-induced changes in receptive field properties of rat dorsal horn neurons. Anesthesiology 1999, 91:772-785. 10.1097/00000542-199909000-00030, 10485789.
16. Villarreal CF, Del Bel EA, Prado WA. Involvement of the anterior pretectal nucleus in the control of persistent pain: a behavioral and c-Fos expression study in the rat. Pain 2003, 103:163-174. 10.1016/S0304-3959(02)00449-9, 12749971.
17. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987, 328:632-634. 10.1038/328632a0, 3112583.
18. Hughes P, Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 1995, 47:133-178.
19. Coggeshall RE. Fos, nociception and the dorsal horn. Prog Neurobiol 2005, 77:299-352.
20. Sandkuhler J. The organization and function of endogenous antinociceptive systems. Prog Neurobiol 1996, 50:49-81.
21. Sun X, Yokoyama M, Mizobuchi S, Kaku R, Nakatsuka H, Takahashi T, Morita K. The effects of pretreatment with lidocaine or bupivacaine on the spatial and temporal expression of c-Fos protein in the spinal cord caused by plantar incision in the rat. Anesth Analg 2004, 98:1093-1098. 10.1213/01.ANE.0000104580.89717.A2, 15041605.
22. Tsuda M, Koizumi S, Inoue K. Role of endogenous ATP at the incision area in a rat model of postoperative pain. Neuroreport 2001, 12:1701-1704. 10.1097/00001756-200106130-00036, 11409742.
23. Nicholas AP, Zhang X, Hokfelt T. An immunohistochemical investigation of the opioid cell column in lamina X of the male rat lumbosacral spinal cord. Neurosci Lett 1999, 270:9-12. 10.1016/S0304-3940(99)00446-2, 10454133.
24. Hamalainen MM, Gebhart GF, Brennan TJ. Acute effect of an incision on mechanosensitive afferents in the plantar rat hindpaw. J Neurophysiol 2002, 87:712-720.
25. Leonard PA, Arunkumar R, Brennan TJ. Bradykinin antagonists have no analgesic effect on incisional pain. Anesth Analg 2004, 99:1166-1172. 10.1213/01.ANE.0000130348.85587.BE, 15385370.
26. Pogatzki-Zahn EM, Shimizu I, Caterina M, Raja SN. Heat hyperalgesia after incision requires TRPV1 and is distinct from pure inflammatory pain. Pain 2005, 115:296-307. 10.1016/j.pain.2005.03.010, 15911156.
27. Wieseler-Frank J, Maier SF, Watkins LR. Central proinflammatory cytokines and pain enhancement. Neurosignals 2005, 14:166-174. 10.1159/000087655, 16215299.
28. Kina VA, Villarreal CF, Prado WA. The effects of intraspinal L-NOARG or SIN-1 on the control by descending pathways of incisional pain in rats. Life Sci 2005, 76:1939-1951. 10.1016/j.lfs.2004.08.038, 15707877.
29. Villarreal CF, Kina VA, Prado WA. Participation of brainstem nuclei in the pronociceptive effect of lesion or neural block of the anterior pretectal nucleus in a rat model of incisional pain. Neuropharmacology 2004, 47:117-127. 10.1016/j.neuropharm.2004.03.002, 15165839.
30. Villarreal CF, Prado WA. Modulation of persistent nociceptive inputs in the anterior pretectal nucleus of the rat. Pain 2007, 132:42-52. 10.1016/j.pain.2007.01.021, 17350762.
31. Stamford JA. Descending control of pain. Br J Anaesth 1995, 75:217-227.
32. Lavand'homme PM, Eisenach JC. Sex differences in cholinergic analgesia II: differing mechanisms in two models of allodynia. Anesthesiology 1999, 91:1455-1461. 10.1097/00000542-199911000-00039, 10551598.
33. Satoh M, Oku R, Akaike A. Analgesia produced by microinjection of L-glutamate into the rostral ventromedial bulbar nuclei of the rat and its inhibition by intrathecal alpha-adrenergic blocking agents. Brain Res 1983, 261:361-364. 10.1016/0006-8993(83)90646-7, 6131729.
34. Iwamoto ET, Marion L. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J Pharmacol Exp Ther 1993, 266:329-338.
35. Li DP, Chen SR, Pan YZ, Levey AI, Pan HL. Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol 2002, 543:807-818. 10.1113/jphysiol.2002.020644, 2290545, 12231640.
36. Zhuo M, Gebhart GF. Tonic cholinergic inhibition of spinal mechanical transmission. Pain 1991, 46:211-222. 10.1016/0304-3959(91)90078-C, 1661000.
37. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002, 71:533-554. 10.1016/S0091-3057(01)00746-8, 11888546.
38. Hamon M, Gallissot MC, Menard F, Gozlan H, Bourgoin S, Verge D. 5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord. Eur J Pharmacol 1989, 164:315-322. 10.1016/0014-2999(89)90472-X, 2759179.
39. Thor KB, Nickolaus S, Helke CJ. Autoradiographic localization of 5-hydroxytryptamine1A, 5-hydroxytryptamine1B and 5-hydroxytryptamine1C/2 binding sites in the rat spinal cord. Neuroscience 1993, 55:235-252. 10.1016/0306-4522(93)90469-V, 8350989.
40. Danzebrink RM, Gebhart GF. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat. Brain Res 1991, 538:64-75. 10.1016/0006-8993(91)90377-8, 2018933.
41. Giordano J. Analgesic profile of centrally administered 2-methylserotonin against acute pain in rats. Eur J Pharmacol 1991, 199:233-236. 10.1016/0014-2999(91)90462-Y, 1954980.
42. Radhakrishnan R, King EW, Dickman JK, Herold CA, Johnston NF, Spurgin ML, Sluka KA. Spinal 5-HT(2) and 5-HT(3) receptors mediate low, but not high, frequency TENS-induced antihyperalgesia in rats. Pain 2003, 105:205-213. 10.1016/S0304-3959(03)00207-0, 2746627, 14499437.
43. Zhuo M, Gebhart GF. Spinal serotonin receptors mediate descending facilitation of a nociceptive reflex from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Brain Res 1991, 550:35-48. 10.1016/0006-8993(91)90402-H, 1888999.
44. Jeong CY, Choi JI, Yoon MH. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol 2004, 502:205-211. 10.1016/j.ejphar.2004.08.048, 15476746.
45. Liu FY, Xing GG, Qu XX, Xu IS, Han JS, Wan Y. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats. J Pharmacol Exp Ther 2007, 321:1046-1053. 10.1124/jpet.106.115204, 17329553.
46. Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 1999, 96:7687-7692. 10.1073/pnas.96.14.7687, 33602, 10393881.
47. Pogatzki EM, Urban MO, Brennan TJ, Gebhart GF. Role of the rostral medial medulla in the development of primary and secondary hyperalgesia after incision in the rat. Anesthesiology 2002, 96:1153-1160. 10.1097/00000542-200205000-00019, 11981156.
48. Vanegas H, Schaible HG. Descending control of persistent pain: inhibitory or facilitatory?. Brain Res Brain Res Rev 2004, 46:295-309. 10.1016/j.brainresrev.2004.07.004, 15571771.
49. Wang Y, Feng C, Wu Z, Wu A, Yue Y. Activity of the descending noradrenergic pathway after surgery in rats. Acta Anaesthesiol Scand 2008, 52:1336-1341. 10.1111/j.1399-6576.2007.01525.x, 19025524.
50. Villarreal CF, Kina VA, Prado WA. Antinociception induced by stimulating the anterior pretectal nucleus in two models of pain in rats. Clin Exp Pharmacol Physiol 2004, 31:608-613. 10.1111/j.1440-1681.2004.04057.x, 15479168.
51. Hayashida K, DeGoes S, Curry R, Eisenach JC. Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 2007, 106:557-562. 10.1097/00000542-200703000-00021, 17325515.
52. Basbaum AI, Fields HL. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978, 4:451-462. 10.1002/ana.410040511, 216303.
53. Eide PK, Hole K. The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity. Cephalalgia 1993, 13:75-85. 10.1046/j.1468-2982.1993.1302075.x, 7684323.
54. Millan MJ. Endorphins and nociception: an overview. Methods Find Exp Clin Pharmacol 1982, 4:445-462.
55. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol 1999, 57:1-164. 10.1016/S0301-0082(98)00048-3, 9987804.
56. Colpaert FC, Tarayre JP, Koek W, Pauwels PJ, Bardin L, Xu XJ, Wiesenfeld-Hallin Z, Cosi C, Carilla-Durand E, Assie MB, Vacher B. Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia. Neuropharmacology 2002, 43:945-958. 10.1016/S0028-3908(02)00119-3, 12423664.
57. Fasmer OB, Berge OG, Hole K. Changes in nociception after lesions of descending serotonergic pathways induced with 5,6-dihydroxytryptamine. Different effects in the formalin and tail-flick tests. Neuropharmacology 1985, 24:729-734. 10.1016/0028-3908(85)90006-1, 3841806.
58. Millan MJ, Seguin L, Honore P, Girardon S, Bervoets K. Pro- and antinociceptive actions of serotonin (5-HT)1A agonists and antagonists in rodents: relationship to algesiometric paradigm. Behav Brain Res 1996, 73:69-77. 10.1016/0166-4328(96)00073-3, 8788480.
59. Laporte AM, Doyen C, Nevo IT, Chauveau J, Hauw JJ, Hamon M. Autoradiographic mapping of serotonin 5-HT1A, 5-HT1D, 5-HT2A and 5-HT3 receptors in the aged human spinal cord. J Chem Neuroanat 1996, 11:67-75. 10.1016/0891-0618(96)00130-5, 8841890.
60. Bonaventure P, Voorn P, Luyten WH, Jurzak M, Schotte A, Leysen JE. Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function. Neuroscience 1998, 82:469-484. 10.1016/S0306-4522(97)00302-3, 9466454.
61. Waeber C, Moskowitz MA. [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn Schmiedebergs Arch Pharmacol 1995, 352:263-275. 10.1007/BF00168556, 8584041.
62. Oyama T, Ueda M, Kuraishi Y, Akaike A, Satoh M. Dual effect of serotonin on formalin-induced nociception in the rat spinal cord. Neurosci Res 1996, 25:129-135.
63. Robles LI, Barrios M, Del Pozo E, Dordal A, Baeyens JM. Effects of K+ channel blockers and openers on antinociception induced by agonists of 5-HT1A receptors. Eur J Pharmacol 1996, 295:181-188. 10.1016/0014-2999(95)00643-5, 8720582.
64. Yoshimura M, Furue H. Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J Pharmacol Sci 2006, 101:107-117. 10.1254/jphs.CRJ06008X, 16766858.
65. Ali Z, Wu G, Kozlov A, Barasi S. The actions of 5-HT1 agonists and antagonists on nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Brain Res 1994, 661:83-90. 10.1016/0006-8993(94)91184-3, 7834389.
66. Zhang Y, Yang Z, Gao X, Wu G. The role of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors in modulating spinal nociceptive transmission in normal and carrageenan-injected rats. Pain 2001, 92:201-211. 10.1016/S0304-3959(01)00259-7, 11323141.
67. Alhaider AA, Wilcox GL. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther 1993, 265:378-385.
68. Xu W, Qiu XC, Han JS. Serotonin receptor subtypes in spinal antinociception in the rat. J Pharmacol Exp Ther 1994, 269:1182-1189.
69. Cornea-Hebert V, Riad M, Wu C, Singh SK, Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 1999, 409:187-209. 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P, 10379914.
70. Maeshima T, Ito R, Hamada S, Senzaki K, Hamaguchi-Hamada K, Shutoh F, Okado N. The cellular localization of 5-HT2A receptors in the spinal cord and spinal ganglia of the adult rat. Brain Res 1998, 797:118-124. 10.1016/S0006-8993(98)00360-6, 9630559.
71. Fonseca MI, Ni YG, Dunning DD, Miledi R. Distribution of serotonin 2A, 2C and 3 receptor mRNA in spinal cord and medulla oblongata. Brain Res Mol Brain Res 2001, 89:11-19. 10.1016/S0169-328X(01)00049-3, 11311971.
72. Wu S, Zhu M, Wang W, Wang Y, Li Y, Yew DT. Changes of the expression of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by complete Freund's adjuvant-induced inflammation. Neurosci Lett 2001, 307:183-186. 10.1016/S0304-3940(01)01946-2, 11438394.
73. Kjorsvik A, Tjolsen A, Hole K. Activation of spinal serotonin(2A/2C) receptors augments nociceptive responses in the rat. Brain Res 2001, 910:179-181. 10.1016/S0006-8993(01)02652-X, 11489268.
74. Obata H, Saito S, Sasaki M, Ishizaki K, Goto F. Antiallodynic effect of intrathecally administered 5-HT(2) agonists in rats with nerve ligation. Pain 2001, 90:173-179. 10.1016/S0304-3959(00)00401-2, 11166984.
75. Sasaki M, Ishizaki K, Obata H, Goto F. Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur J Pharmacol 2001, 424:45-52. 10.1016/S0014-2999(01)01117-7, 11470259.
76. Cardenas CG, Del Mar LP, Scroggs RS. Two parallel signaling pathways couple 5HT1A receptors to N- and L-type calcium channels in C-like rat dorsal root ganglion cells. J Neurophysiol 1997, 77:3284-3296.
77. Cardenas CG, Mar LP, Vysokanov AV, Arnold PB, Cardenas LM, Surmeier DJ, Scroggs RS. Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol 1999, 518(Pt 2):507-523. 10.1111/j.1469-7793.1999.0507p.x, 2269436, 10381596.
78. Bervoets K, Millan MJ, Colpaert FC. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat. Eur J Pharmacol 1990, 191:185-195. 10.1016/0014-2999(90)94146-O, 2150818.
79. Bardin L, Schmidt J, Alloui A, Eschalier A. Effect of intrathecal administration of serotonin in chronic pain models in rats. Eur J Pharmacol 2000, 409:37-43. 10.1016/S0014-2999(00)00796-2, 11099698.
80. Laporte AM, Koscielniak T, Ponchant M, Verge D, Hamon M, Gozlan H. Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands. Synapse 1992, 10:271-281. 10.1002/syn.890100402, 1585260.
81. Morales M, McCollum N, Kirkness EF. 5-HT(3)-receptor subunits A and B are co-expressed in neurons of the dorsal root ganglion. J Comp Neurol 2001, 438:163-172. 10.1002/cne.1307, 11536186.
82. Ali Z, Wu G, Kozlov A, Barasi S. The role of 5HT3 in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Neurosci Lett 1996, 208:203-207. 10.1016/0304-3940(95)12600-7, 8733305.
83. Garraway SM, Hochman S. Serotonin increases the incidence of primary afferent-evoked long-term depression in rat deep dorsal horn neurons. J Neurophysiol 2001, 85:1864-1872.
84. Suzuki R, Rahman W, Hunt SP, Dickenson AH. Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res 2004, 1019:68-76. 10.1016/j.brainres.2004.05.108, 15306240.
85. Green GM, Scarth J, Dickenson A. An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT(3) receptors in the anaesthetized rat. Pain 2000, 89:81-88. 10.1016/S0304-3959(00)00346-8, 11113296.
86. Li P, Kerchner GA, Sala C, Wei F, Huettner JE, Sheng M, Zhuo M. AMPA receptor-PDZ interactions in facilitation of spinal sensory synapses. Nat Neurosci 1999, 2:972-977. 10.1038/14771, 10526335.
87. Li P, Zhuo M. Silent glutamatergic synapses and nociception in mammalian spinal cord. Nature 1998, 393:695-698. 10.1038/31496, 9641681.
88. Fu KY, Light AR, Maixner W. Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hindpaw. J Pain 2001, 2:2-11. 10.1054/jpai.2001.9804, 14622781.
89. Curtin LI, Grakowsky JA, Suarez M, Thompson AC, DiPirro JM, Martin LB, Kristal MB. Evaluation of buprenorphine in a postoperative pain model in rats. Comp Med 2009, 59:60-71. 2703135, 19295055.
90. Pogatzki EM, Niemeier JS, Brennan TJ. Persistent secondary hyperalgesia after gastrocnemius incision in the rat. Eur J Pain 2002, 6:295-305. 10.1053/eujp.2002.0339, 12161095.
91. Zahn PK, Brennan TJ. Primary and secondary hyperalgesia in a rat model for human postoperative pain. Anesthesiology 1999, 90:863-872. 10.1097/00000542-199903000-00030, 10078689.
92. Jones TL, Lustig AC, Sorkin LS. Secondary hyperalgesia in the postoperative pain model is dependent on spinal calcium/calmodulin-dependent protein kinase II alpha activation. Anesth Analg 2007, 105:1650-1656. 10.1213/01.ane.0000287644.00420.49, 18042863.
93. Pogatzki EM, Niemeier JS, Sorkin LS, Brennan TJ. Spinal glutamate receptor antagonists differentiate primary and secondary mechanical hyperalgesia caused by incision. Pain 2003, 105:97-107. 10.1016/S0304-3959(03)00169-6, 14499425.
94. Pogatzki-Zahn EM, Niemeier JS, Sorkin LS, Brennan TJ. [Spinal glutamate receptor antagonists differentiate primary and secondary mechanical hyperalgesia caused by incision]. Schmerz 2006, 20:245-253. 10.1007/s00482-006-0481-8, 16763860.
95. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110. 10.1016/0304-3959(83)90201-4, 6877845.
96. Prado WA. Antinociceptive potency of intrathecal morphine in the rat tail flick test: a comparative study using acute lumbar catheter in rats with or without a chronic atlanto-occipital catheter. J Neurosci Methods 2003, 129:33-39. 10.1016/S0165-0270(03)00197-3, 12951230.
97. Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain 1996, 64:493-501. 10.1016/0304-3959(95)01441-1, 8783314.
98. Lino-de-Oliveira C, Sales AJ, Del Bel EA, Silveira MC, Guimaraes FS. Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression. Brain Res Bull 2001, 55:747-754. 10.1016/S0361-9230(01)00566-4, 11595358.
99. Silberstein SD. Methysergide. Cephalalgia 1998, 18:421-435. 10.1046/j.1468-2982.1998.1807421.x, 9793694.
100. Glennon RA, Metwally K, Dukat M, Ismaiel AM, De los Angeles J, Herndon J, Teitler M, Khorana N. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists. Curr Top Med Chem 2002, 2:539-558. 10.2174/1568026023393787, 12052193.
101. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994, 46:157-203.
102. Miller K, Weisberg E, Fletcher PW, Teitler M. Membrane-bound and solubilized brain 5HT3 receptors: improved radioligand binding assays using bovine area postrema or rat cortex and the radioligands 3H-GR65630, 3H-BRL43694, and 3H-LY278584. Synapse 1992, 11:58-66. 10.1002/syn.890110108, 1318585.
103. Wong DT, Robertson DW, Reid LR. Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortex. Eur J Pharmacol 1989, 166:107-110. 10.1016/0014-2999(89)90689-4, 2806363.